Protandim

• The Company's primary product, Protandim, a dietary supplement, has been clinically proven to reduce the effects of oxidative stress, as well as the progressive rate of cellular aging.
(Small Cap Network)
• Over the past 52 weeks, the stock has traded in the range of $0.64 – $2.07. LifeVantage is a science based nutraceutical company, maker of Protandim, the Nrf2 Synergizer patented dietary supplement.
(Beacon Equity Research)